Uday Kulkarni

Employment

• Christian Medical College & Hospital Professor
  2022 - Present
• Christian Medical College & Hospital Associate Professor
  2018 - 2022
• Christian Medical College & Hospital Assistant Professor
  2016 - 2018
• Lokmanya Tilak Municipal General Hospital and Lokmanya Tilak Municipal Medical College Assistant Professor
  2013 - 2013
• Employees' State Insurance Scheme (ESIS) Hospital Medical Officer
  2012 - 2012
• Lokmanya Tilak Municipal General Hospital and Lokmanya Tilak Municipal Medical College Senior Resident
  2012 - 2012

Education

• Christian Medical College & Hospital DM
  2013 - 2016
• Lokmanya Tilak Municipal General Hospital and Lokmanya Tilak Municipal Medical College MD
  2009 - 2012
• Seth GS Medical College and KEM Hospital MBBS
  2003 - 2009

Projects & Funding

Projects & funding information is unavailable.

Publications (111)

• Recurrent Orogenital Ulcers: A Rare Case of Myeloid Neoplasm Associated with FIP1L1-PDGFRA Rearrangement with Rapid Response to Imatinib
  Indian Dermatology Online Journal 2026 DOI: 10.4103/idoj.idoj_730_25
  +Save
• Outcomes of Adults Age 40 Years and Older With Newly Diagnosed ALL: A Multicenter Registry Analysis From the Hematology Cancer Consortium
  JCO Global Oncology 2026 DOI: 10.1200/GO-26-00090
  +Save
• Acquired Cutis Laxa Secondary to Hematological Malignancy: A Report of Two Cases
  Indian Dermatology Online Journal 2026 DOI: 10.4103/idoj.idoj_1193_25
  +Save
• Aspirin for the Treatment of Ghosal Haematodiaphyseal Dysplasia
  Indian Journal of Hematology and Blood Transfusion 2026 DOI: 10.1007/s12288-026-02437-0
  +Save
• Efficacy of Standard-Dose Versus Low-Dose Nivolumab in Relapsed/Refractory Hodgkin Lymphoma—A Retrospective Analysis
  JCO Global Oncology 2026 DOI: 10.1200/GO-25-00424
  +Save
• Real world outcomes with the use of Inotuzumab Ozogamicin in relapsed/refractory B cell acute lymphoblastic leukemia
  Blood Cancer Journal 2025 DOI: 10.1038/s41408-025-01448-w
  +Save
• Low-dose nivolumab and lenalidomide in relapsed/refractory Hodgkin lymphoma: a single-arm phase 2 trial
  Blood Immunology & Cellular Therapy 2025 DOI: 10.1016/j.bict.2025.100011
  +Save
• Clinical Presentation, Microbiological Profile, Treatment Outcome, and Predictors of Outcome in Patients with Nontuberculous Mycobacteria Bloodstream Infection.
  International journal of mycobacteriology 2025 DOI: 10.4103/ijmy.ijmy_107_25
  +Save
• Efficacy and Safety of Combining r‐ATG With PTCy for GvHD Prophylaxis in Haploidentical HSC Transplantation for Malignancies—A Systematic Review
  Journal of cellular and molecular medicine 2025
  +Save
• Erythroid activity modulates iron regulation in pathological erythropoiesis: A cross-sectional case-control study.
  The Indian journal of medical research 2025 DOI: 10.25259/ijmr_1589_2024
  +Save